Moleculin Biotech, Inc. (MBRX) Net income 2016–2025
Moleculin Biotech, Inc. (MBRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$33.6MFY2025 · since FY2016: -$3.9M → -$33.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.6M | -28.8% |
| FY2024 | -$26.0M | +12.5% |
| FY2023 | -$29.8M | -2.6% |
| FY2022 | -$29.0M | -82.6% |
| FY2021 | -$15.9M | +8.4% |
| FY2020 | -$17.4M | -31.4% |
| FY2019 | -$13.2M | -11.2% |
| FY2018 | -$11.9M | -21.1% |
| FY2017 | -$9.8M | -149.7% |
| FY2016 | -$3.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice